当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析

皓元医药

(688131)

  

流通市值:149.98亿  总市值:149.98亿
流通股本:2.12亿   总股本:2.12亿

皓元医药(688131)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.32亿元,每股收益1.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益313359.39万元,未分配利润100954.56万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产607043.61万元,负债293684.22万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,059,065,717.061,310,942,751.62606,125,018.692,270,177,811.5
营业总成本1,692,413,729.41,083,752,794.05500,107,881.661,900,882,004.66
其他经营收益
营业利润289,384,618.05184,723,905.8274,892,596.81236,817,376.92
利润总额287,425,117.63181,622,375.2373,258,571.58238,355,281.35
净利润231,678,855.86148,696,287.3161,178,293.66197,930,034.58
每股收益
其他综合收益-1,723,831.95-2,272,927.51200,385.5422,673,517.39
综合收益总额229,955,023.91146,423,359.861,378,679.2220,603,551.97
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,715,026,308.813,509,468,693.463,363,203,135.353,174,918,772.7
非流动资产:
非流动资产合计2,355,409,813.772,333,077,224.832,350,325,759.872,330,027,122.57
资产总计6,070,436,122.585,842,545,918.295,713,528,895.225,504,945,895.27
流动负债:
流动负债合计1,610,886,614.771,446,644,840.331,363,851,756.861,260,187,291.8
非流动负债:
非流动负债合计1,325,955,561.831,349,479,419.531,376,317,512.221,340,503,672.54
负债合计2,936,842,176.62,796,124,259.862,740,169,269.082,600,690,964.34
所有者权益(或股东权益):
归属于母公司股东权益合计3,112,196,065.043,023,109,057.762,948,187,946.512,877,877,144.94
股东权益合计3,133,593,945.983,046,421,658.432,973,359,626.142,904,254,930.93
负债和股东权益合计6,070,436,122.585,842,545,918.295,713,528,895.225,504,945,895.27
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,096,179,872.291,342,097,615.26581,435,370.722,360,017,508.13
经营活动现金流出小计2,001,600,478.351,352,528,504.77613,937,047.151,978,057,249.82
经营活动产生的现金流量净额94,579,393.94-10,430,889.51-32,501,676.43381,960,258.31
投资活动产生的现金流量:
投资活动现金流入小计3,302,942,359.662,006,738,023.231,074,094,217.3329,357,419.52
投资活动现金流出小计3,079,541,970.951,736,278,461.611,011,057,176.63813,011,609.64
投资活动产生的现金流量净额223,400,388.71270,459,561.6263,037,040.7-783,654,190.12
筹资活动产生的现金流量:
筹资活动现金流入小计701,021,475.18493,284,158.35291,805,529.861,633,575,712.21
筹资活动现金流出小计497,285,337.95306,405,488.22136,872,625.76842,097,185.26
筹资活动产生的现金流量净额203,736,137.23186,878,670.13154,932,904.1791,478,526.95
汇率变动对现金及现金等价物的影响8,282,087.8514,329,706.168,134,951.467,845,113.98
现金及现金等价物净增加额529,998,007.73461,237,048.4193,603,219.83397,629,709.12
期末现金及现金等价物余额1,403,093,680.461,334,332,721.131,066,698,892.56873,095,672.73
补充资料:
现金及现金等价物的净增加额-461,237,048.4-397,629,709.12
最新报告期:2025-11-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,黄翰漾1.421.942.602025-11-10
中信建投王云鹏,袁清慧,贺菊颖1.432.062.802025-11-09
平安证券叶寅,倪亦道1.461.952.592025-11-01
光大证券曹聪聪,王明瑞1.361.892.452025-10-31
中信证券陈竹,王凯旋,韩世通1.441.882.342025-10-13
TOP↑